As The Stock Falls By -86.81% Year-To-Date, Biolase Inc (NASDAQ: BIOL)’S Stock Continues To Progress In 2024
During the last session, Biolase Inc (NASDAQ:BIOL)’s traded shares were 0.67 million, with the beta value of the company hitting 0.71. The 52-week high for